AIDS vaccine trial exceeds expectations

September 23, 2005

An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.

The trial, conducted in healthy volunteers to determine their immune response to the vaccine, might indicate whether the immune reactions could prevent or control AIDS, reported the Wall Street Journal Friday.

The vaccine, called MRKAd5, uses an adenovirus -- a common-cold virus -- as a missile armed with man-made copies of three AIDS virus genes, has resulted in a stronger-than-expected immune response.

MRKAd5 has boosted such killer T-cells, which seek and destroy human cells infected by HIV by 50-fold to 100-fold -- an immune reaction comparable with successful vaccines for diseases like smallpox or measles, according to Lawrence Corey, principal investigator of the HIV Vaccine Trials Network in Seattle.

However, the vaccine doesn't elicit antibodies, another key element of immune protection.

Copyright 2005 by United Press International

Explore further: Key findings to develop a vaccine against Toxoplasma

Related Stories

Key findings to develop a vaccine against Toxoplasma

October 29, 2015

Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer. Pregnant women who are infected may suffer a miscarriage ...

Deadly fish virus still present in Wisconsin lake

October 23, 2015

In May 2007, hundreds of freshwater drum—also known as sheepshead—turned up dead in Lake Winnebago and nearby Little Lake Butte des Morts, both inland lakes near Oshkosh, Wisconsin. The fish were splotched with red and ...

Human immune cells -- in mice

January 13, 2010

( -- In 1796, English physician Edward Jenner decided to investigate a tale he had often heard -- that milkmaids infected with cowpox became immune to smallpox, a much more dangerous affliction. To test this theory, ...

Recommended for you

NASA's space-station resupply missions to relaunch

November 29, 2015

NASA's commercial space program returns to flight this week as one of its private cargo haulers, Orbital ATK, is to launch its first supply shipment to the International Space Station in more than 13 months.

CERN collides heavy nuclei at new record high energy

November 25, 2015

The world's most powerful accelerator, the 27 km long Large Hadron Collider (LHC) operating at CERN in Geneva established collisions between lead nuclei, this morning, at the highest energies ever. The LHC has been colliding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.